These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30142549)

  • 21. Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism.
    Sarsenbayeva A; Marques-Santos CM; Thombare K; Di Nunzio G; Almby KE; Lundqvist M; Eriksson JW; Pereira MJ
    Psychoneuroendocrinology; 2019 Dec; 110():104445. PubMed ID: 31563732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.
    Frommelt L; Lembke V; Hofmann T; Goebel-Stengel M; Mönnikes H; Wiedenmann B; Klapp BF; Stengel A; Kobelt P
    Peptides; 2013 Jan; 39():111-8. PubMed ID: 23200724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term olanzapine treatment on meal-induced insulin sensitization and on gastrointestinal peptides in female Sprague-Dawley rats.
    Hegedűs C; Kovács D; Kiss R; Sári R; Németh J; Szilvássy Z; Peitl B
    J Psychopharmacol; 2015 Dec; 29(12):1271-9. PubMed ID: 26349558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.
    Kovács D; Hegedűs C; Kiss R; Sári R; Németh J; Szilvássy Z; Peitl B
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):525-30. PubMed ID: 25644372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
    Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
    Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine-induced insulin resistance may occur via attenuation of central K
    Kowalchuk C; Castellani L; Kanagsundaram P; McIntyre WB; Asgariroozbehani R; Giacca A; Hahn MK
    Schizophr Res; 2021 Feb; 228():112-117. PubMed ID: 33434724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin as a feeding suppressant: localization of central action to the cerebral III ventricle.
    Plata-Salamán CR; Oomura Y
    Physiol Behav; 1987; 40(4):501-13. PubMed ID: 3628547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic activation of central AMPK attenuates glucose-stimulated insulin secretion and exacerbates hepatic insulin resistance in diabetic rats.
    Park S; Kim DS; Kang S; Shin BK
    Brain Res Bull; 2014 Sep; 108():18-26. PubMed ID: 25149877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.
    Girault EM; Guigas B; Alkemade A; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):185-95. PubMed ID: 24190543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat.
    Olsson M; Herrington MK; Reidelberger RD; Permert J; Arnelo U
    Peptides; 2007 Jul; 28(7):1416-23. PubMed ID: 17614161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats.
    Park S; Hong SM; Ahn IS
    Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model.
    Park S; Ahn IS; Kim DS
    Life Sci; 2010 Jun; 86(23-24):854-62. PubMed ID: 20388519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
    Guesdon B; Denis RG; Richard D
    Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of olanzapine and haloperidol on the metabolic status of healthy men.
    Vidarsdottir S; de Leeuw van Weenen JE; Frölich M; Roelfsema F; Romijn JA; Pijl H
    J Clin Endocrinol Metab; 2010 Jan; 95(1):118-25. PubMed ID: 19906788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
    Weston-Green K; Huang XF; Lian J; Deng C
    Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in hypothalamic mu-opioid receptor expression following acute olanzapine treatment in female rats: Implications for feeding behavior.
    Krogsbaek M; Larsen NY; Landau AM; Sanchez C; Nyengaard JR
    J Chem Neuroanat; 2023 Oct; 132():102324. PubMed ID: 37557929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.
    da Silva AA; Kuo JJ; Hall JE
    Hypertension; 2004 Jun; 43(6):1312-7. PubMed ID: 15123576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.